Kairos Meridian Perspectives: insights on pharma DTP, omnichannel, go-to-market and AI in commercial strategy

WRITTEN FROM THE WORK, NOT THE SIDELINES

Perspectives

Thought leadership on the life sciences & pharma industries.

WHITE PAPERS

Telehealth call: Cover for the Kairos Meridian white paper on why direct-to-patient (DTP) programs plateau after launch

WHITE PAPER

The DTP program launched. The channel didn’t.

Why some direct-to-patient programs plateau after go-live — and the four numbers that tell you what it is costing your brand.

Download the white paper

BLOG

Omnichannel

Commercial Strategy

Direct-to-Patient (DTP)

Artificial Intelligence

DTC Advertising

Omnichannel

October 14, 2026

Your Next Patient Has an Agent

Pharma leadership team around a laptop, working with an embedded fractional commercial leader

Commercial Strategy

September 27, 2026

Stop Buying Hours. Start Buying a Mandate.

Pharma commercial leadership team reviewing an omnichannel sales plan in a boardroom

Omnichannel

September 25, 2026

The 6:1 ROI Nobody Wanted to Fund

Data on a tablet: AI isn't a journey: the ROAD Trip method for closing the AI adoption gap on pharma commercial teams

Artificial Intelligence

September 22, 2026

AI Isn't a Journey. Success is a Series of Road Trips.

Speaker at a conference: Who should own a pharma direct-to-patient (DTP) program to scale it beyond launch

Direct-to-Patient (DTP)

August 30, 2026

It takes a village to launch a DTP program. It takes a group leading it to scale one.

Patient on a telehealth call: Why pharma direct-to-patient programs plateau after launch, and how to size what it costs

Direct-to-Patient (DTP)

August 15, 2026

The DTP program launched. The channel didn't.